Literature DB >> 16435147

Intra-operative inferior vena cava syndrome in a patient with autosomal dominant polycystic kidney disease.

S A Pierre1, M T Jaeger, D R Siemens.   

Abstract

The renal and hepatic cysts characteristic of autosomal dominant polycystic kidney disease can exert a mass effect on surrounding structures. If this involves the inferior vena cava (IVC), patients usually present with signs and symptoms characteristic of congestive heart failure. However, the absence of these signs or symptoms does not exclude a potentially hemodynamically significant IVC syndrome. This case report describes a patient with no pre-operative evidence of congestive heart failure or IVC compression, who subsequently experienced intra-operative hypotension and hypoxemia due to an IVC syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16435147     DOI: 10.1007/s00345-005-0009-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  10 in total

Review 1.  Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma.

Authors:  Dominique Chauveau; Fadi Fakhouri; Jean-Pierre Grünfeld
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

Review 2.  Laparoscopic management of renal cystic disease.

Authors:  A K Hemal
Journal:  Urol Clin North Am       Date:  2001-02       Impact factor: 2.241

3.  USRDS. 2001 Annual Data Report.

Authors:  L Cooper
Journal:  Nephrol News Issues       Date:  2001-09

4.  Inferior vena caval compression by hepatic cysts: an unusual complication of adult polycystic kidney disease.

Authors:  M Yaqoob; C Saffman; R Finn; A T Carty
Journal:  Nephron       Date:  1990       Impact factor: 2.847

5.  Compression of the inferior vena cava by right renal cysts: an unusual cause of IVC and/or iliofemoral thrombosis with pulmonary embolism in autosomal dominant polycystic kidney disease.

Authors:  D A O'Sullivan; V E Torres; J A Heit; S Liggett; B F King
Journal:  Clin Nephrol       Date:  1998-05       Impact factor: 0.975

6.  Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.

Authors:  Inge H H T Klein; Gerry Ligtenberg; P Liam Oey; Hein A Koomans; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

Review 7.  Clinical management of autosomal dominant polycystic kidney disease.

Authors:  W M Bennett; L W Elzinga
Journal:  Kidney Int Suppl       Date:  1993-07       Impact factor: 10.545

8.  Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.

Authors:  W Uddin; J K Ramage; B Portmann; P Wilson; I Benjamin; K C Tan; R Williams
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Therapeutic dilemmas in patients with symptomatic polycystic liver disease.

Authors:  R H Turnage; F E Eckhauser; J A Knol; N W Thompson
Journal:  Am Surg       Date:  1988-06       Impact factor: 0.688

10.  Obstruction of the inferior vena cava complicating hemodialysis in polycystic kidney disease.

Authors:  J D Raulerson; L I Juncos; T J Fuller; R Cade
Journal:  South Med J       Date:  1979-11       Impact factor: 0.954

  10 in total
  1 in total

1.  Prevalence of Inferior Vena Cava Compression in ADPKD.

Authors:  Xiaorui Yin; Jon D Blumenfeld; Sadjad Riyahi; Xianfu Luo; Hanna Rennert; Irina Barash; Martin R Prince
Journal:  Kidney Int Rep       Date:  2020-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.